CA2191583C - Methods and compositions for modulating morphogenic protein expression - Google Patents
Methods and compositions for modulating morphogenic protein expression Download PDFInfo
- Publication number
- CA2191583C CA2191583C CA002191583A CA2191583A CA2191583C CA 2191583 C CA2191583 C CA 2191583C CA 002191583 A CA002191583 A CA 002191583A CA 2191583 A CA2191583 A CA 2191583A CA 2191583 C CA2191583 C CA 2191583C
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- cell
- reporter gene
- acid fragment
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25525094A | 1994-06-07 | 1994-06-07 | |
US255,250 | 1994-06-07 | ||
PCT/US1995/007349 WO1995033831A1 (en) | 1994-06-07 | 1995-06-07 | Methods and compositions for modulating morphogenic protein expression |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2191583A1 CA2191583A1 (en) | 1995-12-14 |
CA2191583C true CA2191583C (en) | 2007-03-27 |
Family
ID=22967501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002191583A Expired - Fee Related CA2191583C (en) | 1994-06-07 | 1995-06-07 | Methods and compositions for modulating morphogenic protein expression |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0804573A1 (de) |
JP (2) | JPH10505223A (de) |
AU (1) | AU703445B2 (de) |
CA (1) | CA2191583C (de) |
WO (1) | WO1995033831A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5932716A (en) * | 1995-07-26 | 1999-08-03 | Creative Biomolecules, Inc. | Morphogen-responsive regulatory elements |
US6103491A (en) * | 1995-07-26 | 2000-08-15 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
US5834188A (en) * | 1995-07-26 | 1998-11-10 | Creative Biomolecule, Inc. | Methods and compositions for identifying morphogen analogs |
US6090544A (en) * | 1995-07-26 | 2000-07-18 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
US7306903B1 (en) | 1995-07-26 | 2007-12-11 | Curis, Inc. | Methods and compositions for identifying morphogen analogs |
WO1997014812A2 (en) * | 1995-10-16 | 1997-04-24 | Chiron Corporation | Method of screening for factors that modulate gene expression |
AU5558498A (en) * | 1996-11-22 | 1998-06-22 | Akzo Nobel N.V. | Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis |
AU745514B2 (en) * | 1997-05-29 | 2002-03-21 | Curis, Inc. | Modulators of morphogen expression and methods of identifying the same |
JPH11313675A (ja) * | 1998-04-30 | 1999-11-16 | Hoechst Marion Roussel Kk | ヒトbmp−7プロモーターおよびこれを用いた骨関連物質の探索法 |
US7598079B2 (en) | 1998-12-24 | 2009-10-06 | Novation Pharmaceuticals, Inc. | Assay for identifying compounds which affect stability of mRNA |
GB9828709D0 (en) * | 1998-12-24 | 1999-02-17 | Novartis Ag | Assay |
US8426194B2 (en) | 2003-01-21 | 2013-04-23 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating VEGF expression |
US8460864B2 (en) | 2003-01-21 | 2013-06-11 | Ptc Therapeutics, Inc. | Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
US9068234B2 (en) | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
US8283115B1 (en) | 2007-06-20 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation |
US8283116B1 (en) | 2007-06-22 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266683A (en) * | 1988-04-08 | 1993-11-30 | Stryker Corporation | Osteogenic proteins |
BR9206110A (pt) * | 1991-06-05 | 1995-07-11 | Procter & Gamble | Composições terapêuticas para osteoindução |
EP0601129B1 (de) * | 1991-08-30 | 2000-11-15 | Creative Biomolecules, Inc. | Screeningverfahren von morphogenischen Proteinen |
GB9206874D0 (en) * | 1992-03-30 | 1992-05-13 | Connaught Lab | Generation of improved inducible mammalian expression vectors |
US5512483A (en) * | 1993-05-21 | 1996-04-30 | Mcgill University | Expression vectors responsive to steroid hormones |
US5585237A (en) * | 1993-10-25 | 1996-12-17 | Creative Biomolecules, Inc. | Methods and compositions for high protein production from recombinant DNA |
AU1180195A (en) * | 1993-11-16 | 1995-06-06 | Children's Medical Center Corporation | Method of identifying a substance capable of inducing bone formation |
-
1995
- 1995-06-07 CA CA002191583A patent/CA2191583C/en not_active Expired - Fee Related
- 1995-06-07 WO PCT/US1995/007349 patent/WO1995033831A1/en active Application Filing
- 1995-06-07 JP JP8501323A patent/JPH10505223A/ja active Pending
- 1995-06-07 AU AU28223/95A patent/AU703445B2/en not_active Ceased
- 1995-06-07 EP EP95923784A patent/EP0804573A1/de not_active Withdrawn
-
2005
- 2005-08-22 JP JP2005240508A patent/JP2006025796A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0804573A1 (de) | 1997-11-05 |
CA2191583A1 (en) | 1995-12-14 |
WO1995033831A1 (en) | 1995-12-14 |
JPH10505223A (ja) | 1998-05-26 |
JP2006025796A (ja) | 2006-02-02 |
AU703445B2 (en) | 1999-03-25 |
AU2822395A (en) | 1996-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2191583C (en) | Methods and compositions for modulating morphogenic protein expression | |
Orlandi et al. | Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. | |
Ko et al. | Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor δ gene enhancer | |
KR100406299B1 (ko) | Tgf수용체족및/또는bmp수용체족에속하는액티빈수용체유사키나제(alk) | |
JPH07502651A (ja) | 老化細胞由来dna合成阻害因子 | |
US5698389A (en) | Transcriptional promoter of the murine obesity gene | |
JPH0543599A (ja) | TGF―βに対する正常ヒト成長調節性レセプター | |
JP3616089B2 (ja) | 形態形成誘導蛋白のスクリーニング方法 | |
US6071695A (en) | Methods and products for identification of modulators of osteogenic protein-1 gene expression | |
US5849514A (en) | Method of identifying agents that modulate UCP2 promoter activity | |
KR20010071207A (ko) | 단백질 생산 및 전달을 위한 인간 과립구 콜로니-자극인자 유전자의 코딩 영역 상류의 지놈 서열 | |
Kawada et al. | Role of intron 1 in smooth muscle α-actin transcriptional regulation in activated mesangial cells in vivo | |
Umekawa et al. | Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure | |
JP3861134B2 (ja) | タンパク質発現法およびタンパク質発現用コンストラクト | |
CA2303844A1 (en) | Regulators of ucp3 gene expression | |
US6392022B1 (en) | Gene originating in human chondrocyte | |
JP2001517092A (ja) | モルフォゲン発現のモジュレーターおよびモジュレーターを同定する方法 | |
Asselta et al. | Identification of a glucocorticoid response element in the human γ chain fibrinogen promoter | |
Wenstrup et al. | Abnormal differentiation in MC3T3-E1 preosteoblasts expressing a dominant-negative type I collagen mutation | |
CN114957439B (zh) | 绵羊pdgfd、编码pdgfd核酸及其重组慢病毒、宿主细胞与应用 | |
AU3675799A (en) | Methods and compositions for modulating morphogenic protein expression | |
AU773649B2 (en) | Methods and compositions for modulating morphogenic protein expression | |
Degterev | Regulation of elastin gene transcription: characterization of an NF-1 element in the distal promoter | |
Qian | Smooth muscle gamma-actin expression in smooth muscle development and differentiation | |
Agarwal | Regulation of alpha-1 (I) collagen gene transcription by TGF-beta |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |